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Abstract
Objectives—Gaps in vaccination coverage leave populations vulnerable to illnesses. Since the 
1990s, there has been a growing movement to improve vaccination access by giving pharmacists 
the authority to administer vaccines according to state laws. Understanding the variation of 
pharmacist vaccination laws over time is critical to understanding the effect of improving access to 
vaccination services.
Methods—We identified relevant statutes and regulations with the use of Westlaw legal 
databases. A 4-stage coding process identified 220 legal variables of pharmacist vaccination 
authority. Each jurisdiction’s laws were coded against these 220 legal variables. The resulting legal 
dataset was then evaluated to determine whether jurisdictions expanded or restricted pharmacist 
vaccination authorities over time.
Results—From 1971 to 2016, jurisdictions made 627 changes to statutes and regulations relating 
to pharmacist vaccination authority. There were 85 expansions, 3 restrictions, and 22 regulatory 
clarifications. Eight changes were deemed to be unclear, and 479 changes did not substantively 
alter the scope of pharmacist vaccination authority.
Conclusion—Collectively, the laws in 50 states and DC paint a clear picture: the scope of 
pharmacists’ vaccination authority is expanding. Jurisdictions are allowing pharmacists to 
administer more vaccines to younger patients with less direct prescriber oversight. This clear 
expansion of pharmacist vaccination authority stands in contrast to the reservations expressed by 
some physician groups for pharmacists as vaccination providers. However, laws in some states still 
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do not permit pharmacists to vaccinate according to the Advisory Committee on Immunization 
Practices recommendations.
Vaccination is one of the greatest public health achievements of the twentieth century.1 
Systematic vaccination programs have resulted in decreases in illnesses, fewer deaths, longer 
lifespans, and even the eradication of some diseases. Nevertheless, gaps in vaccination 
coverage leave significant proportions of the population vulnerable to illnesses, with 
outbreaks of vaccine-preventable diseases occurring regularly. One perceived barrier to 
vaccination is a lack of adequate access to vaccination services.2
Since the 1990s, there has been a growing movement to improve access to immunization 
services by giving pharmacists the authority to administer vaccines.2–5 Expanding 
pharmacists’ scope of practice to include vaccination significantly increases the number of 
health care providers who can offer vaccination services and significantly improves the 
convenience of those services by authorizing them at community pharmacies frequented by 
prospective patients.2,6 For example, pharmacies frequently have longer operation hours 
than traditional health care providers, permitting busy individuals to get vaccinated on the 
way home from work or while on errands.2,7,8 Moreover, vaccinating retail pharmacies are 1 
possible access point for individuals not currently in the health care system or in rural areas 
with fewer traditional providers.7,9 Increasing pharmacists’ authority also leads to increased 
public awareness of vaccination’s importance and availability through routine interaction 
with pharmacists and advertisements.8,10–13 Finally, pharmacists can supplement the 
vaccinating workforce of health facilities.14 If pharmacists are able to increase vaccination 
rates (as opposed to displacing vaccines normally administered in physician offices), then 
pharmacists can potentially play a significant role in the prevention of future outbreaks and 
even the eradication of some diseases.9
Despite the possible upside, one-third of physicians express reservations about pharmacists 
as vaccination providers.3,15,16 For example, early pharmacist vaccination programs raised 
pediatricians’ concerns that vaccinations of young children outside of the clinical setting 
could disrupt regular office visits.3 One study suggests that some physicians are concerned 
that documentation and communication are inadequate between “alternate vaccinators” and 
primary care providers, and some physicians are concerned that some pharmacists do not 
have adequate training to administer vaccines.15 These reservations, however, have not 
prevented states from granting pharmacists the authority to administer vaccines.
Currently, legal authorities in all states permit pharmacists to administer vaccines to varying 
extents.2,3,17 These authorities are rooted in state statutes and regulations prescribing the 
scope of pharmaceutical practice. These laws vary across jurisdictions in many ways.2,18
Authorities defining pharmacists’ vaccination practice
Constitutions
Constitutions provide the legal framework for government entities to act. Constitutions often 
provide protections against certain government actions, such as due process restrictions on 
state licensure actions against pharmacists. However, constitutions rarely describe specific 
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legal authorizations or restrictions for licensed health care professionals (e.g., whether 
pharmacists can administer vaccines).
Statutes
Statutes are laws passed by state legislative bodies that authorize or prohibit certain 
activities. Statutes can also authorize executive agencies, such as a state health department or 
licensing authority, to promulgate regulations. Statutes are powerful legal authorities that can 
significantly change pharmacists’ vaccination authority. However, passing or amending 
statutes requires opportunity and political will that are not always present.
Regulations
Regulations are laws promulgated by executive agencies to provide procedural or substantive 
specifics as to what the law authorizes or prohibits. Regulations are powerful tools to refine 
pharmacists’ vaccination authority, but new regulations must be consistent with their 
statutory authorization. For example, a regulation cannot authorize pharmacists to administer 
the human papillomavirus (HPV) vaccine to minors if the statute restricts pharmacist 
vaccinations to adult patients. State statutes require executive agencies to undergo a rule-
making process before implementing new regulations which can last several months to 
several years.
Executive orders
Governors can issue executive orders that direct executive agencies’ implementation of their 
statutory authority. In some cases, statutes will provide governors authority to modify 
statutory or regulatory requirements in specified circumstances and may allow governors to 
expand pharmacists’ vaccination authority for outbreak response after declaring a state of 
emergency. Unlike regulations, these orders have no formal process to implement, revise, or 
revoke. Consequently, new administrations will frequently summarily revoke old executive 
orders from previous administrations to promote a new agenda. Executive orders cannot 
contradict a statute or regulation.
Agency guidance
State agencies can provide guidance to aid the public with understanding the requirements of 
statutes and regulations. Agency guidance must be consistent with existing statutes and 
regulations. Moreover, courts view agency guidance as persuasive but not binding. In many 
cases, courts are free to ignore agency guidance when interpreting statutes or regulations.
External guidance
States can incorporate guidance from external entities, such as nongovernmental 
organizations or the federal government, into their legal authorities. Some states incorporate 
the Advisory Committee on Immunization Practices (ACIP)–recommended vaccinations by 
reference in their statutes and regulations. States that adopt this approach allow statutes and 
regulations to adapt to advances in practice, industry, and evidence. However, incorporation 
by reference might be prohibited in some states, and external guidance and 
recommendations cannot be contrary to the state’s statutes or regulations.
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Understanding these authorities is critical to understanding the extent to which pharmacists 
have the legal authority to improve access to vaccination services.19 State laws place 
significant limitations on pharmacists’ scope of practice, including restrictions on the types 
of vaccines that pharmacists can administer and the patient groups that pharmacists can 
serve, among other practice requirements.
Statutes and regulations have the most impact and are the most lasting legal authorities on 
pharmacists’ scope of practice. Examining the changes to these authorities over time would 
provide important insights on the states’ experience with pharmacists’ vaccination 
authorities and provides hints of future national trends. We examined statutes and 
regulations specifically because they are the foundation of pharmacists’ scope of practice 
authority.
Many states passed laws authorizing pharmacists to administer vaccines to improve 
vaccination access with the assumption that increased access will improve vaccination 
rates.2 The study of the effect of law on health outcomes, called legal epidemiology, 
represents a new era in the field of public health law. Legal epidemiology differs from 
traditional legal research methods, which suffer from transparency and reliability issues, by 
using scientific research principles to enhance transparency, reliability, and validity of the 
research results.
With the use of legal epidemiology methods, we created a robust legal dataset that can be 
used in research to identify the specific attributes of laws that have the greatest effect in 
achieving the desired outcome. We announced the existence this legal dataset previously 
(The research protocol for the dataset of pharmacist vaccination laws is available as a 
Supplemental Appendix online).20 This dataset of pharmacist vaccination laws is publicly 
available and contains information on more than 200 legal attributes. These data enable 
ongoing and future research on the specific types of laws that best promote population 
vaccination and other desired outcomes. Pharmacists, professional associates, and 
policymakers can use this data and derivative research to better understand how specific 
types of pharmacist vaccination laws affect health outcomes.18
Methods
The Public Health Law Program (PHLP) at the Centers for Disease Control and Prevention 
(CDC) assessed the statutes and regulations relating to pharmacists’ authority to administer 
vaccines in the 50 states and DC (jurisdictions). PHLP collected and analyzed statutes and 
regulations in effect from 1971 to January 1, 2016.20
We followed generally accepted public health law research guidelines21,22 for policy 
surveillance, including the use of redundant “blind” and “naive” coders, with modifications. 
We identified relevant statutes and regulations with the use of Westlaw legal databases first 
during July 19, 2013, to July 2, 2014, and then updating them on March 29, 2016.
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Search terms
Initial searches used specific terms identified in trade organization data, for example, 
“influenza,” “zoster,” “protocol,” “prescription!,” and “standing order.” These initial 
searches were deemed to be too narrow. We designed subsequent searches to be 
comprehensive, repetitive, and redundant.
Laws containing language regulating pharmacists’ vaccination authority must contain a 
word indicating the regulated profession (i.e., pharmacy, pharmacist) and a word indicating 
the regulated practice (i.e., vaccination, immunization). Consequently, we used repeated 
searches containing “pharmac!,” and “vaccin!” or “immuniz!.” We also used searches using 
“pharmac!,” and “administ!” to capture laws without express vaccination language (e.g., 
administration of drugs). After we found 1 state regulation that used the colloquialism “flu 
shot” instead of formal terminology, we searched all jurisdictions for “pharmac!” and “flu” 
or “shot.”
Identifying historical laws
We identified historical versions of laws with the use of Westlaw’s annotations (e.g., to 
identify renumbered laws), Westlaw’s historical archives (e.g., to obtain prior text), and, in 
rare cases, publicly available state regulatory and legislative resources (e.g., to identify or 
reconstruct earlier text when the Westlaw resources were exhausted). The earliest law we 
identified was from 1971, but most jurisdictions did not have relevant laws before 1990. We 
ended our search for historical laws when a jurisdiction’s laws no longer contained relevant 
text. For example, New York defined the practice of pharmacy in 2008 as including the 
administration of “drugs, medicines, and therapeutic devices,” but the earlier version of the 
law, in effect since 1971, did not include a provision relating to the administration of 
substances. We retained this 1971 law to capture the status of law before the introduction of 
administration authority and to indicate that no earlier versions of this New York law were 
relevant to pharmacists’ vaccination authority.
Coding jurisdictional statutes and regulations
We used a 4-stage coding process to develop the coding questions to analyze the laws. The 4 
stages were: 1) development of a question set; 2) testing questions on a batch of legal 
provisions; 3) analysis of question adequacy; and 4) revision of questions. This iterative 
process resulted in 10 revisions to the coding questions and identified 220 legal variables of 
pharmacist vaccination authority.
Each jurisdiction’s laws were coded against these 220 legal variables by trained legal 
researchers using Public Health Law Research’s policy surveillance tool Workbench. All 
laws in effect on January 1, 2014, and later were redundantly coded by 2 blinded legal 
researchers. For the laws in effect before 2014, 2 blinded legal researchers coded 10 
jurisdictions and a single legal researcher coded the remaining 41 jurisdictions’ laws. 
Coding meetings determined consensus codes when redundant coding was used.
The 220 distinct attributes fall within 4 broad categories of pharmacist vaccination law 
variables. The first category covers the fundamental questions of whether pharmacists can 
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administer substances generally and administer vaccines specifically. The second category 
addresses additional practice requirements for pharmacists who administer vaccines, 
including: 1) training and education; 2) state certification or notification; 3) record-keeping; 
4) reporting; 5) liability insurance; 6) patient notification; 7) facility requirements for 
administration; and 8) authorizations for pharmacists to opt out of vaccination services. The 
third category relates to requirements for a third-party prescriber authorization for vaccine 
administration, including provisions that grant pharmacists prescriptive authority, require a 
patient-specific third-party prescriber authorization, and permit use of general authorizations 
to vaccinate a specified group of patients (e.g., standing orders). The fourth category covers 
restrictions (i.e., patient age, vaccines, modes of vaccine administration) that are specific to a 
type of authorization.
Independent data validation and quality control
Public Health Law Research conducted independent evaluation and quality control for the 
final dataset values with the use of comparison data from 2 different secondary sources.23,24 
Independent evaluators compared 2 random samples of our findings (25 states each) with 
data from these 2 secondary sources. The independent evaluators found 1 coding difference 
for each of the secondary sources, but determined that these differences were due to 
differences in coding scheme (as opposed to coding error).20
Classifying changes in jurisdictional laws
We evaluated a subset of this dataset’s attributes to determine whether jurisdictions 
expanded or restricted pharmacist vaccination authorities over time (i.e., those attributes that 
relate to the substantive scope of practice rather than practice requirements such as reporting 
or recordkeeping). To accomplish this, we used Microsoft Excel to assess whether each 
change in the law was an expansion, restriction, regulatory clarification, or no change to the 
scope of pharmacist vaccination authority using the following groups of legal variables:
• Vaccine authorization type (3 variables)
• Vaccine restrictions (60 variables)
• Modes of vaccine administration (18 variables)
• Minimum patient age restrictions (66 variables)
• Emergency exceptions (5 variables)
• Other select restrictions on authorization types (6 variables)
Changes to the laws were coded as regulatory clarifications if the change was a regulatory 
change occurring subsequent to a statutory change that was ambiguous or silent, or that 
otherwise deferred to executive agencies for clarification. The first change in a jurisdiction’s 
law expressly authorizing vaccination was omitted from this analysis. Changes were deemed 
to be unclear if they included at least 1 criterion indicating an expansion and 1 indicating a 
restriction of vaccination authority. The full dataset, codebook, protocol describing the 
validation process, and full text of all included laws are publicly available (the protocol is 
included as a Supplemental Appendix to this article online).20
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Results
We found a clear national trend to expand pharmacists’ vaccination authority. From 1971 to 
2016, jurisdictions made 627 changes to statutes and regulations relating to pharmacist 
vaccination authority. Of these, 479 changes did not substantively alter the scope of 
pharmacist vaccination authority. There were 85 expansions, 3 restrictions, and 22 
clarifications. Eight changes were deemed to be unclear. California, New Hampshire, and 
North Carolina were the only 3 jurisdictions that changed their laws to restrict pharmacist 
vaccination authority, but all 3 subsequently expanded the authority beyond the initial 
restriction.
Vaccination law restrictions
California—On January 1, 2000, California added a new condition to Cal.Bus. & 
Prof.Code § 4052 that limited immunizations under a standing orderx to those “provided by 
a health care facility, a licensed clinic in which there is physician oversight, or a provider 
who contracts with a licensed health care plan.” All other immunizations required patient-
specific authorizations. California subsequently amended its laws to expand pharmacists’ 
vaccination authority in 2006, 2007, and 2014. In particular, the 2014 enactment of Cal.Bus. 
& Prof.Code § 4052.8 was significant because it authorized pharmacists to “independently 
initiate and administer vaccines” listed on the ACIP immunization schedules to patients 3 
years of age and older.
New Hampshire—On September 23, 2009, New Hampshire enacted a new regulation that 
restricted pharmacists’ vaccination authority.25 Before the regulation’s enactment, a state 
statute authorized pharmacists to “administer influenza vaccines to the general public 
provided all of the criteria in this section have been met….”26 The statute did not contain 
any requirement for a third-party prescriber authorization, such as a prescription or a 
standing order. This law was coded as authorizing prescriptive vaccination authority. The 
2009 regulation added the following requirement: a pharmacist who administers influenza 
vaccines “shall comply with the following procedures: (a) Administer pursuant to a standing 
order from a practitioner practicing within their scope of practice….” This new requirement 
restricted pharmacists’ vaccination authority by adding express language requiring a 
standing order. In 2012, New Hampshire removed this requirement for a standing order and 
granted pharmacists prescriptive authority.27
North Carolina—On December 29, 2009, North Carolina granted pharmacists a temporary 
authority to administer influenza vaccines to patients 14 years of age and older “as a result 
of the H1N1 influenza pandemic of 2009.”28 This new law contained an automatic 
expiration provision. When the automatic expiration was triggered, the expanded 
authorization for influenza vaccination was removed from law. This change was classified as 
a restriction. In 2013, North Carolina expanded its laws to permit influenza vaccine 
administration (and others) beyond the temporary H1N1 expansion.29
Schmit and Penn Page 7
J Am Pharm Assoc (2003). Author manuscript; available in PMC 2018 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Jurisdictions with express vaccination laws
We identified 47 jurisdictions with express language relating to pharmacists’ authority to 
administer vaccines. The remaining 4 jurisdictions (AL, MS, TN, and WA) had laws 
authorizing pharmacists to administer drugs. The legal definition of “drugs” in all of these 
states include substances that are intended for use in the “prevention of disease” or “intended 
to affect the structure or any function of the body.”30–33 We did not find legal language 
prohibiting pharmacists from vaccinating in these states.
Third-party vaccination authorizations
The longitudinal analysis revealed widespread adoption of laws authorizing administration 
pursuant to general authorizations and a recent trend to grant pharmacists prescriptive 
authority to administer vaccines without a third-party prescriber authorization. Despite an 
increasing number of jurisdictions with express vaccination laws, the number of jurisdictions 
requiring pharmacists to have a patient-specific order has remained relatively stagnant 
(Figure 1).
As of 2016, 10 jurisdictions permitted pharmacists to administer a vaccine without a third-
party prescriber authorization in some circumstances (AZ, CA, ID, LA, ME, MT, NH, SD, 
WV, WY). Thirty-five jurisdictions had laws that permit use of general authorizations, such 
as standing orders, to vaccinate patients (AK, AR, AZ, CA, DC, DE, FL, GA, HI, IA, IL, IN, 
KS, KY, MD, ME, MN, MO, MT, NC, ND, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, 
TX, UT, VA, VT, WI, WV). Five jurisdictions had statutes or regulations that do not 
specifically authorize the use of general authorizations or grant prescriptive authority (CO, 
CT, MA, MI, NE); however, the laws in these states did not expressly prohibit general 
authorizations, either.
Patient age restrictions
Our analysis also revealed a dramatic decrease in minimum patient age restrictions. In 2005, 
19 jurisdictions had express patient age restrictions, with an average minimum age of 16.8 
years (median 18, mode 18; 10 states did not have express patient age restrictions). By 2016, 
the average minimum age dropped to 8.76 years (median 7, mode <1) and the number of 
jurisdictions with express age restrictions increased to 39 (8 states did not have express 
patient-age restrictions). This drop in average age restrictions indicates that more states are 
adopting or amending laws that permit pharmacists to vaccinate younger patients.
As of 2016, 7 jurisdictions limited pharmacist vaccinations to adult patients (CT, DE, FL, 
MA, NY, VT, WV). The remaining states had minimum patient age restrictions of 14 years 
(HI, NC), 12 years (ID, MT, SC), 10 years (IL), 9 years (KY, MD, PA, RI), 7 years (AR, LA, 
ME, NJ, OH, OR, WY), 6 years (AZ, IA, KS, MN, WI), 5 years (ND), and 3 years (CA). 
Eight jurisdictions had laws with language indicating no minimum patient age restriction 
(AK, DC, GA, IN, MO, NH, NV, VA), and 8 states (CO, MI, NE, NM, OK, SD, TX, UT) 
did not mention patient age restrictions (AL, MS, TN, and WA do not have express 
vaccination laws).
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Vaccine type restrictions
We also identified a clear trend for jurisdictions to authorize pharmacists to administer more 
vaccines (Figure 2). Three types of laws contributed to this trend: laws that expressly list 
vaccines pharmacists are authorized to administer; laws that authorize administration of any 
ACIP-recommended vaccine; and laws that do not have express language restricting the 
authority to administer specific vaccines. Changes to vaccine restrictions were common 
among pharmacist vaccination laws.
Recently, many jurisdictions have removed vaccine-identifying language in favor of 
language that authorizes any ACIP-recommended vaccine or does not expressly limit the 
administration of any vaccine. In 2016, 8 states authorized the administration of ACIP-
recommended vaccines (CT, FL, ID, MD, ME, NC, OH, SC), 10 states had laws with 
language indicating that there are no restrictions on vaccine types (AR, AZ, HI, IA, IN, MN, 
ND, NM, NV, RI), and 21 states did not have language in statutes or regulation to indicate 
restrictions on vaccine types (AK, CA, CO, DC, DE, IL, KS, KY, LA, MI, MT, NE, NJ, OK, 
OR, PA, TX, UT, VA, VT, WI).
Discussion
Our results show when states have substantively changed their pharmacist vaccination 
authority laws, they have overwhelmingly expanded the vaccination authority. Moreover, the 
only 3 states that were found to restrict pharmacists’ vaccination authority (CA, NH, and 
NC) subsequently expanded the authority beyond the initial restriction. These cumulative 
expansions of pharmacist vaccination authority represent several national trends in 
pharmacists’ vaccination authority: reductions in required physician oversight, reductions in 
minimum patient age requirements, and addition of new vaccines that can be administered.
Many state authorizations that originally required patient-specific authorizations have been 
repealed, amended, or replaced in favor of laws permitting pharmacists to vaccinate multiple 
patients under a single third-party prescriber authorization, such as a standing order. More 
recently, states are going further by authorizing pharmacists to independently prescribe and 
administer vaccines. Given these trends to authorize vaccination with less direct prescriber 
oversight, it is possible that future changes to pharmacist vaccination laws will further 
expand pharmacists’ authority to independently prescribe and administer vaccines.
We have also seen a drop in minimum patient age restrictions for pharmacist vaccination 
services. Given some physicians’ reservations relating to pharmacist-administered 
vaccinations, high minimum patient age requirements may have once reflected safety 
concerns relating to inexperienced providers providing injections to children. However, 
pharmacists now have a growing track record as vaccination providers,3 and the decrease in 
patient age restrictions might represent lawmakers’ growing confidence in pharmacists’ 
competence in vaccinating young patients. Or it could also represent an increasing alignment 
with vaccine recommendations and public health goals. For example, ACIP recommends 
that 11–13-year-old adolescents receive HPV vaccinations, yet many states that authorized 
pharmacists to administer HPV vaccine initially limited it to adult patients only. Some of 
Schmit and Penn Page 9
J Am Pharm Assoc (2003). Author manuscript; available in PMC 2018 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
those states subsequently expanded the authorizations to allow pharmacists to administer 
HPV vaccine for the recommended patient ages.
We also identified a significant trend showing states changing their laws to authorize 
pharmacists to administer new vaccines. Although some of this trend is likely due to the 
advent, approval, or recommendation of new vaccines (e.g., for HPV), many state law 
changes reflected authorizations to administer existing vaccines. Most recently, states have 
begun to adopt laws that authorize pharmacists to administer any vaccine that is 
recommended by ACIP, creating flexibility in the state authorities. It is conceivable that 
jurisdictions prefer laws that tie vaccine restrictions to ACIP recommendations–which are 
updated regularly to reflect advances and new evidence–to continually undergoing tedious 
legislative and rulemaking processes to update existing authorized vaccine lists.
Impact of state law on vaccination rates
Numerous studies have identified the importance of state laws to pharmacist-administered 
vaccinations.2,3,17,19,34 We are aware of no other study of state pharmacist vaccination laws 
that measures more state law requirements (more than 200) over a greater time period. We 
make this data publicly available in recognition that future research is critical to 
understanding the types of laws that best facilitate increased vaccination rates.20 However, 
we note that this research reveals a number of important preliminary findings relating to the 
impact of state law on vaccination rates.
Vaccine and patient age restrictions—ACIP establishes vaccination schedules to 
assist vaccination providers in deciding when to recommend certain vaccines to their 
patients. Many existing state laws prevent pharmacists from administering vaccines as 
recommended. There are 2 primary dimensions to following ACIP recommendations: 
limitations on specific vaccine types and minimum patient age restrictions. On one hand, 
pharmacists cannot administer a recommended vaccine without the legal authority to 
administer it. On the other hand, a pharmacist cannot administer a vaccine as recommended 
if minimum patient age restrictions prevent administration at the recommended time.
Minimum patient age restrictions are a significant barrier to meeting vaccination coverage 
goals. Even if pharmacists could administer any vaccine, the 9 states that prevented 
pharmacists from vaccinating patients under 18 years of age in 2016 effectively bar 
pharmacists from administering any of the vaccines listed in the 2016 ACIP child 
immunization schedules as recommended35; the 2 states permitting vaccination of patients 
as young as 14 years of age allowed pharmacists to administer only the recommended 
booster for meningococcal and annual influenza vaccines for children; the 15 states with 
minimum patient age restrictions from 7 to 12 years allowed pharmacists only to adhere to 
ACIP recommendations for 4 vaccines on the 2016 schedule for children (meningococcal, 
tetanus–diphtheria–acellular pertussis, HPV, and influenza [annual]); pharmacists in the 7 
states with minimum patient age restrictions from 3 to 6 years could administer the final 
dose of 3 more vaccines during the recommended range (inactivated poliovirus, measles-
mumps-rubella, diphtheria–tetanus–acellular pertussis, and influenza [annual]). 
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Consequently, laws with minimum age restrictions by themselves continue to pose 
significant barriers to the timely administration of recommended vaccines by pharmacists.
Third-party prescriber authorization requirements—Advocates of pharmacist 
vaccination laws argue that increased access to vaccination services will promote greater 
vaccination rates through improved convenience.2,6 However, many state laws still require 
patient-specific third-party pre-scriber authorizations to administer some vaccines. Patients 
in those states must first go to a prescribing practitioner to get the authorization before going 
to a pharmacist for vaccination. This is obviously less convenient than obtaining the 
vaccination from the original prescriber. To a lesser extent, we would also anticipate that the 
transaction costs associated with a pharmacist obtaining a general authorization from a third 
party, such as a standing order or collaborative practice agreement, could inhibit some 
pharmacists from providing vaccines permitted by law. In contrast, state laws that permit 
pharmacists to administer ACIP-recommended vaccines without a third-party prescriber 
authorization pose fewer barriers to vaccination access and could have a greater likelihood of 
improving vaccination rates.2
Broad versus specific laws—We identified 47 jurisdictions with statutes and 
regulations that specifically address pharmacists’ vaccination authority. Four states (AL, 
MS, TN, and WA) did not have statutes or regulations that specifically address pharmacist-
administered vaccines. These states have broadly worded laws that authorize drug 
administration. Still, these states do allow pharmacists to administer vaccines, and according 
to Stewart et al., these states all permit pharmacists to administer vaccines on their “own 
authority” (as opposed to a standing order).17 Given that state agencies can issue informal 
guidance that can interpret (but not contradict) statutes and regulations, these states with 
broadly worded laws appear to be interpreting pharmacists’ authority broadly.
Other states might also be liberally interpreting broadly worded statutes and regulations. 
Four states (CO, CT, MA, and MI) authorized pharmacists to administer vaccines pursuant 
to a third-party prescriber authorization but did not specifically address whether the 
authorizations can cover more than 1 patient. However, at least 1 study suggests that these 
states are interpreting these laws as permitting vaccination under a general authorization as 
opposed to a more conservative interpretation (i.e., requiring patient-specific 
authorization).17 In addition, Nebraska’s laws do not address third-party pre-scriber 
authorizations or specifically grant pharmacists’ prescriptive authority; however, Stewart et 
al. describe Nebraska’s laws as permitting pharmacists to administer vaccines on their “own 
authority.”17 Accordingly, these 5 states also might be interpreting their laws broadly (e.g., 
using informal guidance from executive agencies).
There are advantages to using liberal legal interpretations of broadly worded laws. For 
example, informal guidance is easier to change than statutes or regulations, so it is easier to 
keep pace with changing evidence and recommendations. However, there is also less long-
term stability, and agency interpretations are vulnerable to judicial review. More research is 
needed to investigate whether broadly worded laws, such as those in Alabama, Mississippi, 
Tennessee, and Washington, are more effective at promoting vaccination coverage than state 
laws that are specific but grant expansive vaccination authority.
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Laws before 1990
The literature indicates that the first significant pharmacist vaccination programs occurred in 
the mid-1990s. Our data include laws in effect before the 1990s. These laws do not expressly 
mention vaccine administration. However, they do contain language that could be interpreted 
to authorize vaccination. For example, many laws authorize the administration of “drugs,” 
which are often legally defined so broadly (e.g., substances that prevent disease or “affect 
the structure or any function of the body”) that vaccines could reasonably be included. These 
laws in effect before the first major pharmacist vaccination programs in the 1990s were 
included for completeness.
Limitations
This study evaluates only state statutes and regulations relating to pharmacists’ vaccination 
authority. Although statutes and regulations form the foundation of pharmacists’ legal 
authority, they are not the only relevant authorities that impact variations in pharmacist 
practice between jurisdictions (see above). Moreover, states with broadly worded laws could 
provide expansive interpretations of the law through agency guidance. For example, 
Washington was among the first states to permit pharmacists to administer vaccines, but it is 
1 of the 4 states that does not have express vaccination language (it authorizes drug 
administration). State agencies have the authority to provide pharmacists guidance on how to 
interpret laws, but this informal guidance cannot contradict the state statutes or regulations. 
Similarly, expert organizations (e.g., ACIP) provide recommendations on vaccine 
administration, but state statutes and regulations ultimately limit pharmacists’ ability to 
follow these recommendations as well.
Conclusion
Collectively, the laws in the 50 states and DC paint a clear picture: the scope of pharmacists’ 
vaccination authority is expanding. Jurisdictions are allowing pharmacists to administer 
more vaccines to younger patients with less direct prescriber oversight. This expansion 
supports patients seeking greater convenience and access to vaccination services outside of 
traditional clinical settings and hours.
This clear expansion of pharmacist vaccination authority stands in contrast to the 
reservations previously expressed by some physician groups for pharmacists as vaccination 
providers.15 Legal provisions in some jurisdictions might address some provider-pharmacist 
communication and documentation concerns by instituting requirements for reporting and 
recordkeeping for pharmacists who administer vaccines. One thing appears certain: state 
laws support a new norm for pharmacists as alternate vaccination providers.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key Points
Background
• Since the 1990s, states have passed laws giving pharmacists the authority to 
administer vaccines to improve immunization access.
• Limitations of pharmacists’ legal vaccination authority include restrictions on 
types of vaccines, patient age requirements, and third-party prescriber 
requirements.
• New CDC data on pharmacist vaccination laws will facilitate research on how 
specific types of laws affect vaccination rates.
Findings
• Trends in state vaccination laws show pharmacists are administering more 
vaccines to younger patients with less physician oversight.
• As of 2016, 10 jurisdictions permitted pharmacists to independently 
administer a vaccine.
• State laws with restrictions on vaccine types and minimum patient ages 
remain a substantial barrier to pharmacists administering vaccines as 
recommended by the Advisory Committee on Immunization Practices.
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Figure 1. 
Numbers of jurisdictions requiring specific authorization types for pharmacist vaccine 
administrations, 1990–2016.
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Figure 2. 
Numbers of jurisdictions authorizing specific vaccines for pharmacist administrations by 
vaccine type, 1990–2016.
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